Howard Capital Management Inc. Buys 881 Shares of Colgate-Palmolive Company $CL

Howard Capital Management Inc. grew its position in Colgate-Palmolive Company (NYSE:CL) by 18.3% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,707 shares of the company’s stock after purchasing an additional 881 shares during the quarter. Howard Capital Management Inc.’s holdings in Colgate-Palmolive were worth $519,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of CL. Price T Rowe Associates Inc. MD boosted its position in Colgate-Palmolive by 18.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 34,009,078 shares of the company’s stock valued at $3,186,651,000 after acquiring an additional 5,269,140 shares during the last quarter. Nuveen LLC bought a new stake in Colgate-Palmolive during the first quarter valued at $217,593,000. Goldman Sachs Group Inc. boosted its position in Colgate-Palmolive by 34.5% during the first quarter. Goldman Sachs Group Inc. now owns 7,980,387 shares of the company’s stock valued at $747,762,000 after acquiring an additional 2,045,191 shares during the last quarter. Diamond Hill Capital Management Inc. boosted its position in shares of Colgate-Palmolive by 45.0% during the 1st quarter. Diamond Hill Capital Management Inc. now owns 5,562,968 shares of the company’s stock valued at $521,250,000 after purchasing an additional 1,727,105 shares in the last quarter. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in shares of Colgate-Palmolive during the 2nd quarter valued at about $83,837,000. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Down 2.0%

Colgate-Palmolive stock opened at $75.61 on Thursday. Colgate-Palmolive Company has a 1-year low of $75.38 and a 1-year high of $100.18. The firm has a market capitalization of $61.11 billion, a price-to-earnings ratio of 21.24, a price-to-earnings-growth ratio of 4.53 and a beta of 0.34. The firm’s fifty day moving average price is $80.82 and its two-hundred day moving average price is $86.58. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating analysts’ consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. During the same period last year, the firm earned $0.91 earnings per share. The business’s quarterly revenue was up 1.0% compared to the same quarter last year. On average, equities research analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 58.43%.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on CL. Weiss Ratings restated a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, October 8th. Citigroup cut their target price on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a research note on Monday, August 4th. Deutsche Bank Aktiengesellschaft set a $86.00 target price on shares of Colgate-Palmolive in a research note on Friday, October 10th. UBS Group cut their price objective on shares of Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Finally, The Goldman Sachs Group cut their price objective on shares of Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a research report on Thursday, October 2nd. Eight research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $91.50.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.